» Articles » PMID: 15723740

Serum Folate and Homocysteine Levels in Obese Females with Non-alcoholic Fatty Liver

Overview
Journal Nutrition
Date 2005 Feb 23
PMID 15723740
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Folate depletion and hyperhomocysteinemia increase the risk for hepatic alcoholic damage and promote oxidative stress in animals. In addition, some investigators have reported an inverse association between serum folate and body mass index and a positive correlation between total homocysteine and fat mass. We investigated whether there is an association between serum folate and total homocysteine concentrations with the presence of non-alcoholic fatty liver disease (NAFLD) in obese subjects.

Methods: Forty-three obese (body mass index > or =35 kg/m2) patients who underwent bariatric surgery and hepatic biopsy were included. Serum total homocyteine, folate and vitamin B12 concentrations and hepatic enzymes were measured. Liver biopsies were graded for the presence of fat, inflammation, and fibrosis on a scale from 0 to 3. A total histologic score was calculated based on the sum of partial scores. Severe NAFLD was defined as a total score of at least 4 or severe steatosis (partial score for fat = 3).

Results: Severe NAFLD was present in 17 patients. Serum folate concentration was significantly lower in obese patients with NAFLD than in those with normal liver or minimal alterations (9.3 +/- 3.5 versus 12.2 +/- 3.1 ng/mL, P = 0.005). Serum total homocysteine and vitamin B12 concentrations were similar in both groups. An inverse correlation between serum folate concentration and body mass index was observed (r = -0.31, P = 0.046).

Conclusions: In this study, severe NAFLD in obese subjects was associated with lower serum folate concentrations and serum homocysteine and vitamin B12 concentrations were not associated with liver damage in obese subjects.

Citing Articles

Tryptophan Metabolism in Obesity: The Indoleamine 2,3-Dioxygenase-1 Activity and Therapeutic Options.

Engin A, Engin A Adv Exp Med Biol. 2024; 1460:629-655.

PMID: 39287867 DOI: 10.1007/978-3-031-63657-8_21.


Analysis of the mediating role of BMI in associations of different folate forms with hepatic steatosis and liver fibrosis in adolescents in the USA: results from the NHANES 2017-2018.

Wen J, Fei Y, Yuan L, Li K, Xu Q, Cao X Front Endocrinol (Lausanne). 2023; 14:1273580.

PMID: 38116318 PMC: 10728716. DOI: 10.3389/fendo.2023.1273580.


Effects of Folic Acid Supplementation on Liver Enzymes, Lipid Profile, and Insulin Resistance in Patients with Non-Alcoholic Fatty Liver Disease: A Randomized Controlled Trial.

Molaqanbari M, Zarringol S, Talari H, Taghizadeh M, Bahmani F, Mohtashamian A Adv Biomed Res. 2023; 12:103.

PMID: 37288023 PMC: 10241628. DOI: 10.4103/abr.abr_90_22.


Association of serum folate with prevalence of non-alcoholic fatty liver disease among adults (NHANES 2011-2018).

Yao B, Lu X, Xu L, Jiang Y Front Nutr. 2023; 10:1141156.

PMID: 37113299 PMC: 10126427. DOI: 10.3389/fnut.2023.1141156.


Bi-directional causal effect between vitamin B12 and non-alcoholic fatty liver disease: Inferring from large population data.

Fu L, Wang Y, Hu Y Front Nutr. 2023; 10:1015046.

PMID: 36950332 PMC: 10025356. DOI: 10.3389/fnut.2023.1015046.